Xtant Medical CSO Kirschman steps down
Xtant Medical said this month its CSO Dr. David Kirschman resigned from his position as exec veep and chief scientific officer to focus on his role as a board member.
“Dan Goldberger and the Xtant management team have earned my confidence and I feel that under his continued leadership, combined with that of our senior management team, Xtant will continue to build upon its success,” Kirschman said in a prepared statement.
The company also said it added Paul Buckman, Eric Timko and Rudy Mazzocchi to its board of directors, with Jon Wickwire and David Goodman stepping down from their spots on the board. The changes are slated to go into effect on July 2.
“I am excited to announce the addition of these highly qualified individuals to our board of directors, with each bringing extensive medical device management experience to the organization. I would also like to express my sincere gratitude to Mr. Wickwire and Dr. Goodman for their service to the Board and Xtant Medical; their strategic advisement helped guide the company through significant growth and change,” CEO Dan Goldberger said in a press release.